Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Roche to Establish Registries to Monitor Health of HIV-Positive People Exposed to Recalled Antiretroviral Viracept

June 25, 2007

Roche on Thursday said that it plans to establish patient registries to monitor the health of HIV-positive people who were taking the company's recently recalled antiretroviral drug Viracept, the Press Association reports (Moynihan, Press Association, 6/21).

The European Medicines Agency earlier this month recalled Viracept because of contamination. Roche in a statement said that it is recalling all batches of the drug in cooperation with EMA and Swissmedic, Switzerland's drug regulator, in Europe and other undisclosed countries. According to Roche, the drug was recalled after tests indicated that certain batches were contaminated with higher-than-normal levels of methane sulfonic acid ethyl ester -- a chemical normally used in the drug in small quantities.

William Burns, CEO of Roche's pharmaceutical division, said the impurity had been caused by the interaction of two chemicals in a vessel where the drug is produced. Investigators still are trying to determine what occurred in the Swiss plant where the drug is manufactured. It is believed that the contamination might have occurred in March and has affected supplies of the drug for three months (Kaiser Daily HIV/AIDS Report, 6/21).

Advertisement
The company said it is establishing the patient registries for HIV-positive people exposed to elevated levels of EMS, as well as pregnant women and all children who have ever been exposed to the drug, including those exposed in utero. Roche "take[s] the welfare of patients extremely seriously," Burns said, adding, "With the knowledge we have to date, we consider the risk to patients to be low; however, we want to be sure patients can be followed, and these registries will allow us to do just that" (Press Association, 6/21).

Back to other news for June 2007


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement